Fideicomiso Irrevocable F/2061 FHipo
BNZIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.27 | 0.27 | 0.32 | 0.03 |
| FCF Yield | 7.58% | -22.84% | -0.50% | -110.04% |
| EV / EBITDA | 9.75 | -17.60 | 7.58 | 5.99 |
| Quality | ||||
| ROIC | 3.50% | 0.53% | 23.22% | 35.50% |
| Gross Margin | 100.00% | 99.78% | 99.85% | 99.90% |
| Cash Conversion Ratio | 1.15 | -1.51 | -0.04 | -11.41 |
| Growth | ||||
| Revenue 3-Year CAGR | -14.17% | -1.81% | -16.86% | -15.41% |
| Free Cash Flow Growth | 140.68% | -3,474.77% | 99.55% | -6,138.52% |
| Safety | ||||
| Net Debt / EBITDA | 3.06 | -21.07 | 2.67 | 2.33 |
| Interest Coverage | 0.00 | 0.01 | 0.01 | 2.03 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 3,317.71 | 2,713.35 | 1,041,915.07 | 930.68 |